Live Breaking News & Updates on Armata Pharmaceuticals

Stay updated with breaking news from Armata pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP) Short Interest Update

Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP – Get Free Report) was the recipient of a significant decline in short interest in May. As of May 15th, there was short interest totalling 800 shares, a decline of 92.5% from the April 30th total of 10,700 shares. Approximately 0.0% of the shares of the stock are short sold. Based […] ....

Armata Pharmaceuticals Stock Performance , Armata Pharmaceuticals Inc , Armata Pharmaceuticals , Institutional Investors Weigh In On Armata Pharmaceuticals , Securities Exchange Commission , News Ratings For Armata Pharmaceuticals Daily , Seacrest Wealth Management , Get Free Report , Crest Wealth Management , Free Report , Armata Pharmaceuticals Daily ,

Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP) Sees Significant Drop in Short Interest

Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP – Get Free Report) was the recipient of a large decrease in short interest during the month of May. As of May 15th, there was short interest totalling 800 shares, a decrease of 92.5% from the April 30th total of 10,700 shares. Based on an average trading volume of 16,600 shares, […] ....

Armata Pharmaceuticals Company Profile , Seacrest Wealth Management , Armata Pharmaceuticals Inc , News Ratings For Armata Pharmaceuticals Daily , Armata Pharmaceuticals , Hedge Funds Weigh In On Armata Pharmaceuticals , Armata Pharmaceuticals Stock Down , Get Free Report , Crest Wealth Management , Free Report , Pharmaceuticals Stock Down , Armata Pharmaceuticals Daily ,

Anticipation mounts as Insmed's bronchiectasis therapy nears phase 3 completion

Anticipation mounts as Insmed's bronchiectasis therapy nears phase 3 completion
biopharma-reporter.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biopharma-reporter.com Daily Mail and Mail on Sunday newspapers.

Filippos Maniatis , Boehringer Ingelheim , Armata Pharmaceuticals ,

Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Posts Quarterly Earnings Results, Misses Expectations By $0.41 EPS

Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Posts Quarterly Earnings Results, Misses Expectations By $0.41 EPS
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Armata Pharmaceuticals Stock Performance , Securities Exchange Commission , Earnings History For Armata Pharmaceuticals , Armata Pharmaceuticals , Seacrest Wealth Management , News Ratings For Armata Pharmaceuticals Daily , Armata Pharmaceuticals Inc , Get Free Report , Crest Wealth Management , Free Report , Armata Pharmaceuticals Daily ,

ARMP Stock Earnings: Armata Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024

ARMP Stock Earnings: Armata Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Armata Pharmaceuticals , Armata Pharmaceuticals Misses , Market News , Stock Advice , Misses Revenue ,